immunohistochemistry
Showing 1 - 25 of 2,981
Endometrial Cancer Trial in Zagazig (Tissue Biopsy)
Completed
- Endometrial Cancer
- Tissue Biopsy
-
Zagazig, Ash Sharqia Governorate, EgyptZagazig university
Nov 27, 2023
P53 Immunohistochemistry Abnormal Staining in Endometrial Cancer
Completed
- Endometrial Cancer
- p 53 immunohistochemistry positive staining and relation to stages ,pathological types and grading
-
Alexandria, EgyptHossam Hassan El Sokkary
Sep 13, 2022
Oral Cancer by S100A7 Immunohistochemistry Signature-based
Recruiting
- Oral Neoplasm
- Standard of Care Histopathology
- STRATICYTE Assessment
-
Edmonton, Alberta, Canada
- +2 more
Nov 11, 2022
Positron Emission Radiomics With PSMA Radioligands on Newly
Not yet recruiting
- Prostate Cancer
- Immunohistochemistry (IHC) analysis
- (no location specified)
Apr 6, 2023
Profiles of Expression in HPV+ Versus HPV Head and Neck Cancers
Not yet recruiting
- Head and Neck Cancer
- PCR - Immunohistochemistry - Immunolabelling
- (no location specified)
Nov 13, 2023
Iris Trial in Assiut (Immunohistochemistry analysis)
Not yet recruiting
- Iris
- Immunohistochemistry analysis
-
Assiut, EgyptHassan Lotfy
Jul 29, 2022
Inhibitor of Apoptosis Protein Overexpression on Recurrence Rate
Not yet recruiting
- Cancer of Cervix
- Apoptosis
- Immunohistochemistry
- (no location specified)
Nov 17, 2023
Schistosoma Related Bladder Diseases.
Not yet recruiting
- Schistosoma Haematobium
- Immunohistochemistry staining,
- microscopic examination of urine
-
Assiut, EgyptAssiut University Hospital
Jul 4, 2023
Drug Effect Trial in Ismailia (pulpotomy procedure and Histological evaluation, Immunohistochemistry Protocol for Fibronectin
Recruiting
- Drug Effect
- pulpotomy procedure and Histological evaluation
- +2 more
-
Ismailia, EgyptSuez Canal University
May 26, 2022
Survival Rate of HER2-Low Breast Cancer Patients
Completed
- HER2 Low Breast Carcinoma
- immunohistochemistry (IHC) and in situ hybridization (ISH) Test
- (no location specified)
Mar 2, 2023
Breast Cancer Trial (Trastuzumab Deruxtecan)
Not yet recruiting
- Breast Cancer
- Trastuzumab Deruxtecan
- (no location specified)
Jul 10, 2023
Cirrhotic Cardiomyopathy Based on Point-of-care
Recruiting
- Cirrhotic Cardiomyopathy
- +2 more
- Echocardiographic assessment
- Histopathology and Immunohistochemistry
-
Sector-12, Chandigarh, IndiaDr. Madhumita Premkumar
Oct 18, 2023
Ambiguous Melanocytic Proliferation
Not yet recruiting
- Melanoma
- Immunomarkers
-
Strasbourg, FranceLes Hôpitaux Universitaires de Strasbourg
Oct 11, 2021
Fascin-1 in Colorectal Carcinoma
Recruiting
- Cancer of Colon
- Immunohistochemistry
-
Sohag, Egypt
- +1 more
Oct 30, 2022
Dental Implants, Soft Tissue Inflammation, Immunohistochemistry Trial in Liège (Experimental healing abutment)
Completed
- Dental Implants
- +5 more
- Experimental healing abutment
-
Liège, BelgiumHospital University of Liège (CHU-Ulg)
Apr 24, 2023
HER3 Expression in Non-Small Cell Lung Cancer
Recruiting
- Non-small Cell Lung Cancer
- Archival tissue specimen and immunohistochemistry staining
-
Miami, Florida
- +1 more
Mar 14, 2023
Excision Repair Cross Complementation Group 1 in Laryngeal
Not yet recruiting
- Laryngeal Squamous Cell Carcinoma
- Immunohistochemistry
- (no location specified)
Apr 15, 2023
PTEN Expression in Functional and Pathological Endometrial
Completed
- Endometrial Hyperplasia
- Endometrial Adenocarcinoma
- routine stain by H&E.
-
Sohag, EgyptMaisa Hashem Mohammed
Jul 13, 2022
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester
Terminated
- Clear Cell Renal Cell Carcinoma
- +3 more
- panobinostat
- +7 more
-
Buffalo, New York
- +1 more
Aug 11, 2022
Glioma, Malignant Trial in London (PET-MRI, Brain tumour biopsy)
Not yet recruiting
- Glioma, Malignant
- PET-MRI
- Brain tumour biopsy
-
London, United KingdomKing's College London
Jun 8, 2022
Epithelial Mesenchymal Transition and Periodontitis
Recruiting
- Periodontitis
- +5 more
- Modified Widman flap
- Gingivectomy
-
Baghdad, IraqCollege of Dentistry, University of Baghdad
May 30, 2022
Ependymoma Trial in Pittsburgh (biological, drug, other)
Recruiting
- Ependymoma
- HLA-A2 restricted synthetic tumor antigen
- +5 more
-
Pittsburgh, PennsylvaniaChildren's Hospital of Pittsburgh of UPMC
Oct 23, 2022
IGF1R And p95HER2 as Prognostic Factors in Non Small Cell Lung
Completed
- Non Small Cell Lung Cancer
- Protein expression by immunohistochemistry and immunofluorescence
-
Rozzano, Milan, ItalyIstituto Clinco Humanitas
Sep 8, 2022
Oral Potentially Malignant Disorders (OPMDs) With STRATICYTE™
Recruiting
- Mouth Diseases
- STRATICYTE™ Test
-
Birmingham, Alabama
- +3 more
May 2, 2023
Respiratory Tract Dysplasia or Lung Cancer, Head and Neck
Recruiting
- Esophageal Cancer
- +3 more
- immunohistochemistry staining method
- +3 more
-
Aurora, ColoradoUniversity of Colorado Cancer Center at UC Health Sciences Cente
Nov 1, 2022